HYQVIA is a Once-a-Month* SubQ Ig1
With HYQVIA, you have the option to infuse using 1 needle, 1 infusion site, 1 time a month, in the comfort of your own home. If you would feel more comfortable, HYQVIA [Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase] can also be administered by a healthcare professional at your doctor's office, clinic, or hospital.
More Free Time Every Month
Infusing once a month (every 3 or 4 weeks) instead of every week offers more flexibility and can mean more free time every month.
Help Your Body Fight Off Infections1
Just 1 HYQVIA infusion a month (every 3 or 4 weeks) can help your body fight off bacterial and viral infections. As demonstrated in the clinical trial, once-a-month HYQVIA helped reduce the risk of serious infections.
The FDA standards for efficacy (if a treatment works) is only one acute serious infection per year. In the HYQVIA clinical study, patients experienced significantly less than that.
The study included 87 patients with primary immunodeficiency (PI) with the main goal of measuring how many serious bacterial infections patients taking HYQVIA experienced over the course of one year.
What Makes HYQVIA Different?1,2
Conventional subQ Ig treatments require multiple infusions a month, with multiple needles, to receive your monthly dose.
HYQVIA is the only once-a-month (taken every 3 or 4 weeks) subQ Ig with Recombinant Human Hyaluronidase (hy–al–uron–i–dase) and Ig. The Recombinant Human Hyaluronidase temporarily increases the amount of Ig that can be absorbed in the body compared to other subQ treatments.
It's the reason you can infuse your monthly dose of HYQVIA [Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase] using 1 needle, 1 infusion site, 1 time a month. A second site can be used at the discretion of the physician and patient based on tolerability and total volume.
HYQVIA is supplied
as a dual-vial unit and is infused sequentially through 1 needle set: 1. Recombinant Human Hyaluronidase (HY) and 2. Human Immune Globulin Infusion 10% (IG).